‘All tests we do at FMD are aimed at finding the root cause of your health problem. These are not the usual diagnostic tests that you do, but much, much more.’
The gut microbiome plays a critical role in mediating the effects of diet and other factors on health, including digestive, immune, metabolic and neuroendocrine functions. Assessing GI health with the proper tools can help practitioners get to the root cause of chronic illness.
Reporting Time: 2-4 weeks
Stool Test
Best and Honest Price
Product Description
The GI-MAP (Microbial Assay Plus) is unique in the field of comprehensive stool testing. It relies exclusively on quantitative polymerase chain reaction (qPCR) technology to detect parasites, bacteria, fungi, etc by targeting the specific DNA of the organisms tested. The GI-MAP is designed to detect microbes that may be disturbing normal microbial balance or contributing to illness as well as indicators of digestion, absorption, inflammation, and immune function.
What is unique about the GI-MAP test?
The Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample with state of the art, quantitative polymerase chain reaction (qPCR) technology. qPCR technology is used routinely in clinical and academic research because it provides highly-accurate quantification, as well as high levels of sensitivity and specificity.
Benefits of doing GI-MAP testing:
GI-MAP Allows for the Personalized Treatment Plans and Informative Retests
The GI-MAP’s accuracy and reliability allows practitioners to create personalized treatment protocols to address gut dysfunction based on which infections are urgent, which areas of the gut are already optimized, and which areas should be addressed after an infection is resolved.
Additionally, the quantification offers a remarkable ability to see how treatment modalities are working because a retest after treatment can show whether a parasite has resolved, dysbiosis has improved, and more.
Who Should Have the GI-MAP Comprehensive Stool Analysis Done?
Almost every patient can benefit from a GI-MAP gut health assessment. Some patients are looking to achieve optimal health, while other patients have been chronically ill and frustrated without a diagnosis for years.
Some conditions that that definitely benefit from GI Map testing are:
Autoimmune diseases
IBS/IBD
ADHD, Autism, etc
Digestive complaints, diarrhoea or constipation
Brain fog
Skin problems, like acne and psoriasis
Mood disorders, depression, and anxiety
Diabetes and weight loss issues
Can Infants and Children Benefit from the GI-MAP?
Yes. The GI-MAP is commonly used in infants and children, and can provide insight into conditions related to Attentional Deficit Hyperactivity Disorder, Autism, and digestive complaints.
What is Reported on GI-MAP Test Results?
The GI-MAP is designed to detect microbes that may be disturbing normal microbial balance or contributing to illness as well as indicators of digestion, absorption, inflammation, and immune function.
The following is a listing of the microorganisms found on the GI-MAP:
Page 1
Page 2
Page 3
Page 4
Page 5
Page 1
PATHOGENS
The GI-MAP® includes pathogens (bacterial, parasitic, and viral) commonly known to cause intestinal gastroenteritis. It’s important to note that not all individuals with positive findings for pathogens will present with symptoms. Many factors, including the health of the individual, the transient nature of some pathogens, and the presence and expression of virulence factors all contribute to an individual’s symptoms.Toxins are a type of virulence factor produced by certain pathogens. Since GI-MAP is a DNA-based test, results reflect the levels of pathogenic strains carrying the toxin genes, not the levels of any toxins that may be produced.BACTERIAL PATHOGENS
Campylobacter
C. difficile Toxin A
C. difficile Toxin B
Enterohemorrhagic E. coli
E. coli O157
Enteroinvasive E. coli/Shigella
Enterotoxigenic E. coli LT/ST
Shiga-like Toxin E. coli stx1
Shiga-like Toxin E. coli stx2
Salmonella
Vibro cholerae
Yersinia enterocolitica
PARASITIC PATHOGENS
Cryptosporidium
Entamoeba histolytica
Giardia
VIRAL PATHOGENS
Adrenovirus 40/41
Norovirus GI
Norovirus GII
Page 2
H. pylori
Recent studies have shown that nearly 50% of the world’s population may harbor H. pylori. And, although many carriers are asymptomatic, H. pylori is known to have a causative role in ulcers, chronic gastritis, and stomach cancer.
Additionally, in early phases of colonization, patients may experience hypochlorhydria followed by a change to hyper aciduria. Over time, additional H. pylori strains may colonize, including those with Virulence Factors and increased disease potential.
Virulence Factor, babA
Virulence Factor, cabA
Virulence Factor, cabPAI
Virulence Factor, dupA
Virulence Factor, iceA
Virulence Factor, opiA
Virulence Factor, vacA
NORMAL/COMMENSAL BACTERIA
Trillions of microorganisms inhabit the human intestine to make up a complex ecosystem that plays an important role in human health. Commensal bacteria extract nutrients and energy from our diets, maintain gut barrier function, produce vitamins (biotin and vitamin K), and protect against colonization by potential pathogens.
Commensal Bacteria
Akkermansia Mucinophilia
Bacteroides fragilis
Bifidobacterium spp.
Clostridia (class)
Enterobacter spp.
Enterococcus spp.
Escherichia spp.
Faecalbacterium prausnitzii
Lactobacillus spp.
Bacteria Phyla
Bacteroidetes
Firmicutes
Firmicutes/Bacteroidetes Ratio
Page 3
OPPORTUNISTIC/OVERGROWTH MICROBES
Many bacteria measured on the GI-MAP are considered opportunistic pathogens, as they only cause disease and illness in some individuals, particularly the immune-compromised. Many individuals come into contact with opportunistic bacteria and experience no symptoms. Most sources consider these microbes to be normal in the stool. However, they can cause gastroenteritis and inflammation at high levels in vulnerable patients. Symptoms may include diarrhea, loose stools, abdominal pain, or even constipation.
Overgrowth and excessive colonization by opportunistic bacteria may occur when the commensal bacteria are impaired by poor diet, antibiotic use, parasitic infection, or a weakened immune system. When intestinal permeability is present (see zonulin), these microbes could escape the lumen of the gut and infect extraintestinal sites.
ADDITIONAL DYSBIOTIC/OVERGROWTH BACTERIA
Enterococcus faecalis
Enterococcus faecium
Methanobacteriaceae (family)
Morganella morganii
Pseudomonas spp.
Pseudomonas aeruginosa
Staphylococcus spp.
Staphylococcus aureus
Streptococcus spp.
POTENTIAL AUTOIMMUNE TRIGGERS
Citrobacter spp.
Citrobacter freundii
Fusobacterium spp.
Klebsiella spp.
Klebsiella pneumoniae
Mycobacterium avium
Prevotella copri
Proteus spp.
Proteus mirabilis
————————————
FUNGI/YEAST
Fungal organisms are commonly found in the human digestive tract, but fungal overgrowth can cause illness in susceptible individuals. Fungal growth may be localized in the body. For instance, Candida spp. may be high in the large intestine but normal in the small intestine, and vice versa. In a patient with suspected fungal overgrowth, additional tests may be necessary to understand the complete picture of fungal overgrowth. Urinary D-arabinitol or antibodies to Candida are sometimes used.
Candida albicans
Candida spp.
Geotricum spp.
Microsporidia spp.
Rhodoturula spp.
VIRUSES
OPPORTUNISTIC VIRUSES
CMV- Cytomegalovirus
EBV- Epstein Bar Virus
Page 4
PARASITES
A parasite is an organism that lives and feeds on a host organism at the expense of the host. The GI-MAP tests for pathogenic parasites and protozoa (some of which are non-pathogenic) most commonly occurring in the GI tract. Sources of exposure should be identified and eliminated to prevent reinfection.
PROTOZOA
Blastocystis hominis
Chilomastix mesnelli
Cyclospora cayetanenensis
Dientamoeba fragilis
Endolimax nana
Entamoeba coli
Pentatrichomonas hominis
WORMS
Ancyclostroma duodenale
Ascaris lumbricoides
Necator americanis
Trichuris trichiura
Taenia solium/saginada
INTESTINAL HEALTH MARKERS
DIGESTION
Elastase-1
Steatocrit
IMMUNE RESPONSE
SIgA
Anti-gliadin SIgA
INFLAMMATION
Calprotectin
GI MARKERS
β-Glucuronidase
Occult Blood – FIT
ADD-ON TESTS
Zonuli
Page 5
ANTIBIOTIC RESISTANCE GENES
The GI-MAP includes results for detection of antibiotic resistance genes in the microbiome. If an antibiotic resistance gene is present, then that class of antibiotics is designated POSITIVE for antibiotic resistance. A positive result for the presence of resistance genes for a given antibiotic indicates that the antibiotic is not an ideal choice for an antibiotic protocol.Antibiotic resistance genes apply to all of the microorganisms found in the fecal sample. Since microbes can rapidly share DNA under stress, the presence of antibiotic resistance in any organism is reason enough to avoid that drug class.
Reporting Time: 2-4 weeks
Stool Test 
Best and Honest Price
